A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation
Clinical trial NCT05181540 · TERMINATED
Trial details
- NCT number
- NCT05181540
- Sponsor
- Angiocrine Bioscience
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-21
- Primary completion
- 2023-12-29
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.